Texas Biotechnology Announces First Quarter Release and Conference Call Schedule

Apr 23, 2001, 01:00 ET from Texas Biotechnology Corporation

    HOUSTON, April 23 /PRNewswire Interactive News Release/ -- Texas
 Biotechnology Corporation (Amex:   TXB) today announced plans to release first
 quarter financial results on Thursday, May 3, 2001.  A conference call has
 been scheduled for Thursday afternoon, May 3, at 3:00 pm EST.
     To participate in the call, dial (800) 230-1093 and ask for the Texas
 Biotechnology conference call.  The international dial-in number is
 612-332-0634.  A replay of the conference call will also be available
 beginning at 6:30 PM EST on Thursday, May 3, 2001 and will end on Monday,
 May 7, 2001 at 11:59 PM EST.  To access the replay dial (800) 475-6701 in the
 United States and (320) 365-3844 for International access.  The access code
 for the replay is 583891.  In addition, the conference call will be available
 live on the Company's web site (www.tbc.com).  A replay of the conference call
 will also be available on the Company's web site.
     Texas Biotechnology is a biopharmaceutical company focused on the
 discovery, development and commercialization of small molecule drugs to treat
 a variety of vascular diseases including thrombosis, pulmonary hypertension,
 heart failure and asthma.
     For additional information regarding the conference call, please contact
 Ann Tanabe at Texas Biotechnology (713) 796-8822 extension 184.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X47524243
 
 

SOURCE Texas Biotechnology Corporation
    HOUSTON, April 23 /PRNewswire Interactive News Release/ -- Texas
 Biotechnology Corporation (Amex:   TXB) today announced plans to release first
 quarter financial results on Thursday, May 3, 2001.  A conference call has
 been scheduled for Thursday afternoon, May 3, at 3:00 pm EST.
     To participate in the call, dial (800) 230-1093 and ask for the Texas
 Biotechnology conference call.  The international dial-in number is
 612-332-0634.  A replay of the conference call will also be available
 beginning at 6:30 PM EST on Thursday, May 3, 2001 and will end on Monday,
 May 7, 2001 at 11:59 PM EST.  To access the replay dial (800) 475-6701 in the
 United States and (320) 365-3844 for International access.  The access code
 for the replay is 583891.  In addition, the conference call will be available
 live on the Company's web site (www.tbc.com).  A replay of the conference call
 will also be available on the Company's web site.
     Texas Biotechnology is a biopharmaceutical company focused on the
 discovery, development and commercialization of small molecule drugs to treat
 a variety of vascular diseases including thrombosis, pulmonary hypertension,
 heart failure and asthma.
     For additional information regarding the conference call, please contact
 Ann Tanabe at Texas Biotechnology (713) 796-8822 extension 184.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X47524243
 
 SOURCE  Texas Biotechnology Corporation